Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check6 days agoChange DetectedRevision bump: v3.4.2 has been added and v3.4.1 removed, indicating a minor platform update with no visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; there are no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Glossary display and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision to v3.4.0. Removed older Last Update Submitted that Met QC Criteria, No FEAR Act data, and revision v3.3.4.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This updates the page's revision history.SummaryDifference0.0%

- Check56 days agoChange DetectedExpanded the Locations section with a comprehensive, multi-country list of trial sites, including numerous U.S. states and international regions.SummaryDifference3%

- Check78 days agoChange DetectedPublications section updated to state that these publications are automatically filled in from PubMed and may not necessarily be about the study; revision tag updated from v3.2.0 to v3.3.2, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.